Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 3 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Hyperphagia 3Short Bowel Syndrome 1Sepsis 1Pena Shokeir syndrome, type 1 1Neoplasms 1Malnutrition 1Inflammation 1Infections 1Ileus 1Bites and Stings 1Advanced Malignant Neoplasm 1

Interventions

Cyclophosphamide 1499Cisplatin 1434Paclitaxel 1339Radiotherapy 1310Carboplatin 1266Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 697Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × soybean oil, phospholipid emulsion × Clear all
NCT01943409 2025-02-03

Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils

University Health Network, Toronto

Phase 4 Completed
303 enrolled 16 charts

Bites and Stings, Hyperphagia, Infections, Inflammation, Neoplasms, Sepsis, Malnutrition, Ileus

NCT03122886 2024-12-17

Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin

Mayo Clinic

Phase NA Completed
19 enrolled 9 charts
Other neoplasm

Advanced Malignant Neoplasm

NCT04555044 2023-12-27

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

Baxter Healthcare Corporation

Phase 4 Completed
101 enrolled 29 charts

Pena Shokeir syndrome, type 1, Hyperphagia, Short Bowel Syndrome

NCT00292279 2008-05-14

The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients

Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd

Phase 3 Completed
206 enrolled

Hyperphagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡